Search bioRxiv⌕ Search

bioRxiv · 10.1101/2023.04.14.536854

Cross-subject Mapping of Neural Activity with Restricted Boltzmann Machines

Abstract

Subject-to-subject variability is a common challenge in generalizing neural data models across subjects. While many methods exist that map one subject to another, it remains challenging to combine many subjects in a computationally efficient manner, especially with features that are highly non-linear such as when considering populations of spiking neurons or motor units. Our objective is to transfer data from one or more target subjects to the data space of one or more source subject(s) such that the neural decoder of the source subject can directly decode the target data when the source(s) is not available during test time. We propose to use the Gaussian-Bernoulli Restricted Boltzmann Machine (RBM); once trained over the entire set of subjects, the RBM allows the mapping of target features on source feature spaces using Gibbs sampling. We also consider a novel computationally efficient training technique for RBMs based on the minimization of the Fisher divergence, which allows the gradients of the RBM to be computed in closed form, in contrast to the more traditional contrastive divergence. We apply our methods to decode turning behaviors from a comprehensive spike-resolved motor program - neuromuscular recordings of spike trains from the ten muscles that control wing motion in an agile flying Manduca sexta. The dataset consists of the comprehensive motor program recorded from nine subjects driven by six discrete visual stimuli. The evaluations show that the target features can be decoded using the source classifier with an accuracy of up to 95% when mapped using an RBM trained by Fisher divergence. Significant StatementIn this study, we address the variability of neural data across subjects, which is a significant obstacle in developing models that can generalize across subjects. Our objective is to create a task-specific representation of the target subject signal in the feature space of the source subject. Our proposed RBM architectures achieve highly flexible and accurate cross-subject mapping with few assumptions. Our Fisher RBM improved the previous state of the art method by 300%. Our methods show promise in generalizing features of complex neural datasets across individuals, tuning neural interfaces to subject-specific features, and leveraging data across multiple subjects when experiments are limited in time or completeness.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Angjelichinoski, M., Wu, S., Putney, J., Sponberg, S., Tarokh, V.. 2023-04-14. Cross-subject Mapping of Neural Activity with Restricted Boltzmann Machines. https://doi.org/10.1101/2023.04.14.536854

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗